Trial intelligence / Profile preview

Domperidone in Pediatric Acute Gastroenteritis

NCT02699385Phase 3Terminated

Sponsor
Janssen Pharmaceutical
Start
Dec 2015
Primary completion
Aug 2017
Modality
Small Molecules
Countries
6
01

Overview

A Phase 3 trial of domperidone in acute gastroenteritis, sponsored by Janssen Pharmaceutical. Started Dec 2015; status: terminated.

02

Drugs

domperidone
03

Conditions

acute gastroenteritis

Beyond the preview

Go deeper on NCT02699385.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02699385.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call